Views from the Other Side of the Looking Glass: Reflections on My Journey with Ovarian Cancer [Paperback]

Here I come with a book that talks about ovarian cancer. This book is written by Terry Downey. The title is Views from the Other Side of the Looking Glass: Reflections on My Journey with Ovarian Cancer. The format of this book is paperback. Come with 200 pages, I hope you can learn more about ovarian cancer from this book.

Book Description

Something was wrong—very wrong. Even the receptionist knew it. They would fit me in. Suddenly I was on a high-speed train—going someplace that I did not want to go. I didn’t have a reservation. I didn’t have a destination. It didn’t matter. I had the symptom. I could come on board.

As the train sped rapidly down the track, my primary care physician arranged an array of appointments with other physicians and various diagnostic tests. Descriptions of the pictures of my inner body did not verify the presence or absence of cancer. Instead they suggested a diverse assortment of diagnoses. It was like having to choose an answer for a multiple-choice question but choosing the answer that I liked best—most likely a fibroid—was not an option.

Views from the Other Side of the Looking Glass: Reflections on My Journey with Ovarian Cancer captures author Terry Downey’s experiences with a silent but deadly cancer. Downey describes finding herself on a high speed train going places that she did not want to go. As she progressed through diagnosis, surgery, chemotherapy, and radioimmune therapy, those who made the journey with her helped to transform her feelings of hopelessness and despair into feelings of hope and courage.

Product Details

• Paperback: 200 pages
• List Price: $16.95 (Discount may awaiting for you)
• Author: Terry Downey
• Publisher: iUniverse, Inc.
• Publication Date: April 13, 2005
• Language: English
• ISBN-10: 0595347096
• ISBN-13: 978-0595347094
• Product Dimensions: 9 x 6 x 0.5 inches
• Shipping Weight: 12 ounces

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Ovarian Cancer (State of the Art Series (Remedica)) [Paperback]

Here I come with a book that talks about ovarian cancer. This book is written by Robert C., Jr. Bast and Maurie Markman. The title is Ovarian Cancer (State of the Art Series (Remedica)). The format of this book is paperback. Come with 239 pages, I hope you can learn more about ovarian cancer from this book.


Book Description

Ovarian cancer remains one of the major causes of cancer mortality in women throughout the world with a 5-year survival rate of approximately 30 per cent for patients with advanced-stage disease. Over the last two decades, our understanding of the molecular and cellular biology of ovarian cancer has dramatically increased. Our main challenge in the next decade is to accelerate progress in the clinical management of ovarian cancer by translating research findings from ovarian cancer biology to clinical practice, such that we can improve the diagnosis and treatment of this disease.

This involves not only the development of new biomarkers, drugs, and vaccines, but also their evaluation by means of trials that measure biological endpoints as well as clinical activity. Given the challenges and opportunities ahead of us, this is a particularly appropriate time to take stock of our current understanding of ovarian cancer and our ability to diagnose and treat the disease. The book identifies recent advances as well as the shortcomings of current practice, and places an emphasis on the latest translational studies.

"Ovarian Cancer: State of the Art" is authored by experts who have made significant contributions to ovarian cancer research in their specific field of interest, and provides a comprehensive, critical review of the rapidly expanding literature base.

Product Details

• Paperback: 239 pages
• List Price: $39.95 (Discount may awaiting for you)
• Author: Robert C., Jr. Bast and Maurie Markman
• Publisher: Remedica Books
• Publication Date: May 2009
• Language: English
• ISBN-10: 1905721536
• ISBN-13: 978-1905721535
• Product Dimensions: 8.2 x 5.8 x 0.6 inches
• Shipping Weight: 13.6 ounces

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Sarah's Rain [Paperback]

Here I come with a book that talks about ovarian cancer. This book is written by Ava Vanyo. The title is Sarah's Rain. The format of this book is paperback. Come with 268 pages, I hope you can learn more about ovarian cancer from this book.

Book Description

Sarah MacLaurin was a successful lawyer at a prestigious firm. Well known for being impeccably dressed, well groomed, and sharp as a tack, it disturbed her coworkers when she suddenly became withdrawn, sullen, and sloppy.


Product Details

• Paperback: 268 pages
• List Price: $15.00 (Discount may awaiting for you)
• Author: Ava Vanyo
• Publisher: Lulu.com
• Publication Date: July 31, 2007
• Language: English
• ISBN-10: 1411641361
• ISBN-13: 978-1411641365
• Product Dimensions: 9 x 6 x 0.6 inches
• Shipping Weight: 1 pounds

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 


The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Ovarian Cancer with Expert Consult (Early Diagnosis and Treatment of Cancer Series). [Hardcover]

Here I come with a book that talks about ovarian cancer. This book is written by Robert E. Bristow and Deborah K. Armstrong. The title is Ovarian Cancer with Expert Consult (Early Diagnosis and Treatment of Cancer Series). The format of this book is hardcover. Come with 256 pages, I hope you can learn more about ovarian cancer from this book.

Book Description

Each volume in the Early Detection and Treatment of Cancer Series is packed with practical, authoritative information designed to cover the full range of diagnostic procedures, including bronchoscopic, pathologic, radiologic, and surgical aspects. You'll be able to:

• Decide the safest, shortest, least invasive way to reach an accurate diagnosis
• Stage the disease, and
• Choose the best initial treatment for early stages

Based on current proof in the literature, authors provide clinical, hands-on tools to help you make informed decisions on precisely what tests and imaging studies are needed to diagnose and stage each type of cancer.

Practical, authoritative, and highly-illustrated, this volume in the brand new Early Detection and Treatment of Cancer series covers current protocols and the latest advances in diagnostic imaging and molecular and serologic markers for ovarian cancer. Apply expert recommend on the best "next-step" plan for different demonstrations and tips for less invasive protocols.

Get clinical, hands-on tools to help you make informed decisions on precisely what tests and imaging studies are needed for accurate diagnosis and staging. Clear figures, tables, and boxes illustrate step-by-step care of the full range of problems encountered. Better manage your patients with procedural video clips and more on the included CD-ROM. The small size and convenient format make this an ideal purchase for diagnostic reference.

• Outlines the steps after diagnosis to guide you through formulating a treatment or patient care plan.
• Emphasizes important points-such as vaccines, paracentesis, and laparoscopic procedures for staging-with "key points" boxes at the beginning of each chapter and pedagogic features throughout.
• Summarizes the process of accurately diagnosing and staging cancer in a logical, almost algorithmic, approach for easy reference.
• Discusses the treatment of early-stage disease so you have clear options for care.
• Complements the procedures outlined in the text with full-color photographs and line drawings to reinforce your understanding of the material.
• Features a CD-ROM showing video clips of diagnostic procedures, as well as all of the images, tables, and drawings from the text to help you better manage your patients.

Review

"It is an excellently written, comprehensive, and up-to-date reference text on the subject. It has 26 contributors, 25 of whom are from the US, and one from Tel Aviv, Israel, but is global in its perspective of the topics covered. It is a glossy hardback that is easily readable and of average portable size."
Early Diagnosis and Treatment of Cancer Series: Ovarian Cancer. March 2010

"...I would recommend this text most highly and look forward to other books in the series, in the hope that future titles might include coverage of the other gynecological malignancies."
Acta Obstetricia et Gynecologica Scandinavica, March 2010

"...this book would be a very worthwhile addition to the library of any gynaecological cancer multidisciplinary team or an oncology trainee or researcher wishing an up-to-date overview of the subject."
Journal of Obstetrics and Gynaecology, May 2010

Product Details

• Paperback: 256 pages
• List Price: $152.00 (Discount may awaiting for you)
• Author: Robert E. Bristow and Deborah K. Armstrong
• Publisher: Saunders
• Publication Date: November 3, 2009
• Language: English
• ISBN-10: 1416046852
• ISBN-13: 978-1416046851
• Product Dimensions: 10.5 x 7.5 x 0.6 inches
• Shipping Weight: 1.8 pounds

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Ovarian Cancer: State of the Art and Future Directions in Translational Research (Advances in Experimental Medicine and Biology) [Paperback]

Here I come with a book that talks about ovarian cancer. This book is written by George Coukos (Editor), Andrew Berchuck (Editor), Robert Ozols (Editor). The title is Ovarian Cancer: State of the Art and Future Directions in Translational Research (Advances in Experimental Medicine and Biology). The format of this book is paperback. Come with 318 pages, I hope you can learn more about ovarian cancer from this book.


Book Description


Aegean Conferences is an independent, nonprofit, educational organization directed and managed by the scientific community. The board is made up of nine researchers/scientists in various disciplines from Harvard, Brown, University of Pennsylvania, UCSD, Princeton, Biovista and the Foundation for Biomedical Research Academy of Athens. The board both invites and approves unsolicited proposals for Conferences in all fields of Science, Engineering, Arts, and Humanities. The purpose of the Conferences is to bring together individuals with common interests to examine the emerging and most advanced aspects of their particular field.


The Symposium on Ovarian Cancer: State of the Art and Future Directions means to bring together international experts interested in the development of prognostic, novel diagnostic and therapeutic tools for ovarian cancer. The meeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances in clinical research and translational science in ovarian cancer and define areas of future research opportunities and priorities.


Product Details

• Paperback: 318 pages
• List Price: $169.00 (Discount may awaiting for you)
• Author: George Coukos (Editor), Andrew Berchuck (Editor), Robert Ozols (Editor)
• Publisher: Springer
• Publication Date: November 19, 2010
• Edition: Softcover reprint of hardcover 1st ed. 2008 edition
• Language: English
• ISBN-10: 1441923969
• ISBN-13: 978-1441923967
• Product Dimensions: 9.2 x 6.1 x 0.7 inches
• Shipping Weight: 1.1 pounds

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 


The information and opinions expressed here are collected from related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Ovarian Cancer: Your Guide to Taking Control (Patient Centered Guides) [Paperback]

Here I come with another book that talk about ovarian cancer. This book is written by Kristine Conner and Lauren Langford. The title is Ovarian Cancer: Your Guide to Taking Control (Patient Centered Guides). The format of this book is paperback. Come with 600 pages (that's a lot page for a book :D), I hope you can learn more about ovarian cancer from this book.

Book Description

This unique guide for ovarian cancer offers women crucial medical information to improve the opportunity for lengthy remission and cure, as well as emotional support for the journey. Although many ovarian cancers are discovered after they have spread, having information about surgery and best practices can be life-saving.

For example, choosing a surgeon from the new specialty of gynecologic oncology for staging and de-bulking surgeries strongly impacts survival. Women require to at least consider newer chemotherapy and biological treatments in research trials. Women also want to hear the stories of others who live with the ambiguity of remission.

This book includes:

• Ten things to know at the time of diagnosis, for optimal outcome
• How choosing a gynecologic oncology surgeon impacts survival
• When and how you can consider newer treatments, now in clinical trials
• Stories of dozens of women living with ovarian cancer, some for many years
• "Questions for Your Doctor" for all decision points
• A focus on epithelial cancers, the most common and difficult to treat, with additional information on germ cell, sex cord-stromal cell, and low malignant potential ovarian cancers
• Noted cancer writer Kristine Conner and patient advocate Lauren Langford provide ovarian cancer patients with a supportive and much-needed resource.

Product Details

• Paperback: 600 pages
• List Price: $70.99 (Discount may awaiting for you)
• Authors: Kristine Conner and Lauren Langford
• Publisher: Patient Centered Guides
• Edition: 1st
• Publication Date: January 1, 2003
• Language: English
• ISBN-10: 0596500165
• ISBN-13: 978-0596500160
• Product Dimensions: 9.1 x 7 x 1.1 inches
• Shipping Weight: 1.9 pounds

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 


The information and opinions expressed here are collected from many related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Is There Any Relation Between HPV And Ovarian cancer

In this post i'm gonna talk about "Is there any relation between HPV and Ovarian cancer ?"

HPV is a family of viruses with close to 200 strains. It infects the outermost layer of skin or the genitals called the squamous epithelium. HPV gets its name from the telltale warts or papillomas that it causes in these areas. Since HPV is a cancer-causing virus that also thrives in the epithelium, scientists have wanted to find out if ovarian tumors may also be caused by HPV.

The first study on HPV and ovarian cancer was performed in 1987, when Dr. Raymond H. Kaufman and his colleagues discovered HPV-6 DNA in 10 out of 12 patients with ovarian cancer. Following studies, however, have indicated no conclusive relation between HPV and tumors in the ovaries. These include a 1989 study headed by Dr. Jonathan Leake and studies by Dr. Robert McLellan, Drs. Ann-Marie Beckmann and Anne-Marie Trottier in 1990, 1991 and 1995, respectively.

In 1998, however, a study in China by doctors of the Jilin City Center Hospital discovered strong relations between ovarian growths and HPV types 16 and 18, the same HPV types that lead cervical cancer. Another study in the same year by a British team led by Dr. Tom Manolistas also indicate a relation between HPV 16 and ovarian tumors.

In 1999, Dr. Maarit Antilla and colleagues did a high-sensitivity analysis on 98 epithelial ovarian tumors as well as reviewed all the prior HPV-ovarian tumor studies performed with a total of 175 samples. They concluded that HPV is "highly impossible" to lead epithelial ovarian cancer.

Research performed in the past 10 years have been alikely contradicting. A 2003 study performed by doctors from the Inner Mongolia Medical College in China discovered that 36% of epithelial ovarian tumors in 50 cases had HPV-16.

Another study in 2005 discovered HPV-16 in 60% of ovarian tumors analyzed, but concluded that it was statistically insignificant. The researchers, led by Esra Kuscu of the Baskent University School of Medicine in Turkey, proved that HPV may cause some ovarian tumors by interacting with the tumor suppressing gene known as p53.

This was further strengthened by another study by Funda Atalay and colleagues at the Ankara Oncology Research and Educational Hospital. Out of 94 patients with ovarian cancer, they discovered 6 with HPV-16 and 2 with HPV-33.

In different, 20 ovarian tumors analyzed in 2006 by Jeffrey Quirk and his team were negative for HPV types 16, 18, and 33. Another case of HPV-related ovarian squamous cell cancer was informed widely by Dr. Jasper Verguts of the Belgian University Hospital Gasthuisberg in 2007. In Italy, 3 out of 71 patients with ovarian epithelial tumors were informed to have HPV in 2008.

In 2008, an article published by Giovanna Giordana and colleagues found that HPV, when present in ovarian growths, may not be the driving cause of tumors.

In the same year Dr. Brigitte Ronnett and her team confirmed that cancerous cervical tumors may very well tour or metastasize to the ovaries. It means that HPV-positive ovarian tumors may have perhaps come from alike growths in the cervix.

In 2011, Japanese researchers from the University of Toyama in Japan informs a case of ovarian squamous cell carcinoma that metastasized 8 years after a woman had a part of her cervix removed because of cervical tumors. One study published in 2008 is at odds with these findings, however. A group led by Nicolas Wentzensen of the University of Heidelberg in Germany tested for metastatic cervical tumor cells in 74 ovarian tumors but discovered none.

My conclusion

Basically,  the relation between HPV and ovarian cancer is still debatable. While there are cases where HPV was discovered in ovarian epithelial tumors, it is still not obvious how it got there and how it can be linked to cancer. The only sure thing is that HPV in epithelial ovarian tumors are still very uncommon.

Source:
>>  gynecology-obgyn.factoidz.com

Image:
>> Wikipedia





All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

No Time to Die:: Living with Ovarian Cancer [Paperback]

Here I come with a book that talks about ovarian cancer. This book is written by Liz Tiberis. The title of this book is No Time to Die:: Living with Ovarian Cancer. The format of this book is paperback. Come with 336 pages, I hope you can learn more about ovarian cancer from this book.


Book Description

In 1993 Liz Tilberis looked to have everything. She was a working mother with a family who loved her. As editor-in-chief of Harper's Bazzar, she lived at the center of the glamorous world of international fashion and was widely recognized as one of the most powerful people in the industry. And in 1993, Liz Tilberis was diagnosed with Stage III ovarian cancer.

Suddenly she was dealed with with the challenge of a lifetime, joining the ranks of the 175,000 women in America with Ovarian cancer. She underwent major surgery, grueling chemothereapy, and, eventually, when the cancer recurred, a life-threatening bone marrow transplant. Through it all, she refused to let the disease get the better of her, continuing to participate fully in her life as wife, mother, and career woman. And she educated herself about the disease that threatened her life.

Finally, Tilberis deduced that she developed ovarian cancer as a result of infertility treatments she underwent years earlier--a link that the medical establishment has been reluctant to aknowledge. Her experience led Tilberis to become president of the Ovarian Cancer Research Fund and to address countless issues surrounding the devastating disease.

From diagnosis through recovery and recurrence, and on to a rich, rewarding, transformed life, No Time to Die is a frank, no-holds-barred look into the world of fashion and a candid account of a battle with a debilitating illness.

Approaching every obstacle with optimism, humor and grace, Liz Tilberis has written a story that celebrates life and the ultimate triumph of a courageous, determined, and passionate woman.

Product Details

• Paperback: 336 pages
• List Price: $15.00 (Discount may awaiting for you)
• Author: Liz Tiberis
• Publisher: Harper Paperbacks
• Publication Date: April 1, 1999
• Language: English
• ISBN-10: 0380732262
• ISBN-13: 978-0380732265
• Product Dimensions: 7.9 x 5.2 x 1 inches
• Shipping Weight: 12.8 ounces

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 


The information and opinions expressed here are collected from many related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Let's Understand More Deeply About Stage 3 Ovarian Cancer

In this post i'm gonna talk about "understanding more deeply about stage 3 ovarian cancer"

Stage III ovarian cancer has some sub-stages in order of progressing severity. There are;

1. IIIA
Stage IIIA, explained by the American Cancer Society, is diagnosed when cancer can be looked during surgery with the naked eye on one or both ovaries, but no cancer can be grossly look in the abdomen. Only under a microscope, cancer can be seen in abdominal biopsies in this stage, and no cancer is discovered in the lymph nodes.

2. IIIB
Stage IIIB involves one or both of the ovaries, and cancer in the abdomen is grossly visible during surgery but the tumors are 2 cm or smaller. Again, no lymph node involvement is present

3. IIIC
The last sub-stage, Stage IIIC, involves cancer in one or both ovaries, and lymph nodes are cancerous and/or there are tumors larger than 2 cm in the abdomen.

Symptoms of stage 3 ovarian cancer

Symptoms of ovarian cancer exclusively become real once the disease is more advanced, but early ovarian cancer may also have symptoms. The Mayo Clinic lists abdominal fullness or bloating, constipation, frequent urination, pelvic pain and pain with intercourse as symptoms. Because these symptoms can be alike to symptoms of other illnesses, it is notable to get stubborn symptoms evaluated by a health care provider.

Diagnosis of stage 3 ovarian cancer

A pelvic exam, CA-125 blood test and ultrasound can all detect ovarian cancer, but a definitive diagnosis and staging needs a biopsy and surgery. A biopsy of the ovary is exclusively taken during surgery, in accordance with the American Cancer Society.

Treatment of stage 3 ovarian cancer

In accordance with the National Cancer Institute (NCI), treatment for Stage III ovarian cancer exclusively includes chemotherapy and surgery. 

Chemotherapy may be provided either intravenously or intraperitoneally, in which the chemotherapy is placed into the abdominal cavity through a port. If more than 1 cm of cancer remains, combination chemotherapy and/or clinical trials may be recommended. 

Surgery may include removal of the tumor, removal of the uterus and one or both fallopian tubes and ovaries , and removal of the omentum, a fold of abdominal lining. If there is less than 1 cm of cancer remaining after surgery, the NCI recommends chemotherapy, typically combination chemotherapy consisting of more than one cancer drug.

Have you heard about a cancer killer fruit that is said 10.000 times more powerful than chemotherapy ? If haven't, check this post

Prognosis of stage 3 ovarian cancer

The American Cancer Society lists five-year survival rates, taken from the NCI SEER database, and the rates differ in accordance with sub-stage. The five-year survival rates estimate the percentage of individuals who will be alive five years after diagnosis. For Stage IIIA ovarian cancer, the five-year survival rate is 45 %; Stage IIIB is 39 %; and Stage IIIC is 35 %.

Source:
>>  Livestrong

Image:
>> Metrohealth





All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Does Abortion Send Up The Opportunity Of Acquiring Ovarian Cancer ?

In this post, i'm gonna talk about "does abortion send up the opportunity of acquiring ovarian cancer ?"

Although, there are likely relations between induced abortion and a higher risk of cancer because spontaneous and induced abortions are often not divided in the literature, it is hard to draw definitive conclusions build upon it.

In addition, inconsistencies exist between studies and from country to country. There have been a number of studies performed in the past twenty years, however, that show an increased risk of cervical and ovarian cancer when there has been a history of previous abortion(s). Women who have had more than one previous abortion seem especially to be at a higher risk of ovarian cancer, while research shows that childbirth gives women with security from cancers of the reproductive system. A higher incidence of rectal cancer also looks to be associated to induced abortion, despite further research is required to study this relationship.

Studies of cancer of the ovary have presented conflicting proof about a likely relation with induced abortion. As late as 1990 Larissa Remennick commented in the Journal of Epidemiology and Community Health that the likely effect of abortion on ovarian cancer had hardly ever been examined.

Yet in 1995, Bernal and colleagues informed that “ovarian cancer cases show important fetal loss”. With four abortions, the relative risk increase to 3.66 – meaning a 266 % increased risk. Regrettably, the study made no difference between spontaneous and induced abortions.

A year later, Chen and colleagues specified that incomplete pregnancies, including abortions, do not give women with the protective influence of full-term pregnancies against the onset of ovarian cancer. This is significant, because the risk of developing ovarian cancer has been indicated to decrease with the number of full-term pregnancies.

Finally, Albrektsen and colleagues have specified that childbirth equips protection against cancers of the reproductive system, thanks to “a mechanical shed of malignant or pre-malignant cells at each delivery”. Such protection is not discovered in pregnancies ended by induced abortion.

McPherson and colleagues discovered that for ovarian cancer “a history of ever (versus never) having had an induced abortion was a factor that remained statistically significant.” The increase in risk is 150 % (relative risk = 2.5). They also specified that the time of a spontaneous abortion in a woman’s life was also significant – “a miscarriage late in reproductive life followed by lack of a subsequent full-term pregnancy” is a risk factor for ovarian cancer. It is unfortunate that they give no discussion of the sequence of pregnancy interruptions because induced abortion is known to help to later spontaneous abortions. If a consistent pattern turned out to be, for instance:

1. Induced abortion of first pregnancy;
2. Subsequent spontaneous abortions;
3. Ovarian cancer, the finding would be significant.

My Conclusion

Research shows that after an induced abortion (and mainly after more than one abortion), there is a real higher risk of contracting cervical, ovarian, or rectal cancer, despite the exact links are inconclusive. 


Researchers have discovered that a full-term pregnancy producing in childbirth looks to give a protective influence for women against cancers of the reproductive system. It is fantastic that with the increase in cancers of the reproductive system in women, there is so little treaty on whether or not induced abortion(s) increase women’s risk of cancer. As in other areas of the influences of abortion on women’s health, more objective studies are required.

Source:
>> Deveber

Image:
>> static.mediamatic.nl






All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Love You So Much: A mother and daughter's shared memoir, breaking the silence of ovarian cancer from across the miles [Paperback]

Here I come with a book that talks about ovarian cancer. This book is written by Victoria Zacheis Greve and Karen Greve Young. The title of this book is Love You So Much: A mother and daughter's shared memoir, breaking the silence of ovarian cancer from across the miles. The format of this book is paperback. Come with 354 pages, I hope you can learn more about ovarian cancer from this book.

Love you so much, a shared memoir is the story of Vicki and Karen, a mother and daughter writing in separate voices about the nearly five years in which they battle Vicki's ovarian cancer, plot a wedding, fight with infertility, experience the joy of pregnancy, navigate the first and last days of marriage, begin and retire from careers, move across continents, visit each other as often as possible, and decide to write a book about it all. Along their journey, they found that life doesn't stop with a cancer diagnosis - sometimes it even quicken, as theirs certainly did.

More than thirty thousand women are diagnosed with ovarian cancer each year in North America and the UK alone. Any of them could have written about her cancer experience, and many have. What is unique about this book is that it is the shared story of a mother and daughter, each of them writing from her unique perspective about coping with cancer as life moves forward in unpredictable ways.

This story is one of the lasting heritages of Vicki Greve, a woman who survive through her fight against ovarian cancer with style and grace. It was written by women for women and their families, to which millions of women - and men - will relate. Proceeds will be donated in support of cancer research.

Product Details

• Paperback: 354 pages
• List Price: $18.95 (Discount may awaiting for you)
• Author: Victoria Zacheis Greve and Karen Greve Young
• Publisher: Summertime
• Publication Date: August 19, 2011
• Language: English
• ISBN-10: 190488136X
• ISBN-13: 978-1904881360
• Product Dimensions: 8 x 5 x 1 inches
• Shipping Weight: 12.8 ounces

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from many related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Is It Okay For You To Grab IVF After Ovarian Cancer Treatment ?

In this post i'm gonna talk about "Is it okay for you to grab IVF after ovarian cancer treatment ?"

Let's learn about basic of IVF, first !

In vitro fertilisation (IVF) is a method to help some couples who can't gain pregnant normally, so they can get pregnant. This is a high-tech treatment where sperm and eggs are carried together in the laboratory.

Usually, women who have IVF treatment apply drugs or hormone injections to provoke their ovaries to make more eggs. This is known as ovarian stimulation. The women's eggs are then gathered to be fertilised in the laboratory.

Now. the problem is...

There has been some attention that IVF may increase the risk of matters in the ovaries, and especially the risk of ovarian cancer.

Many of the studies into the relation between IVF, ovarian stimulation, and ovarian cancer have compared women who have had IVF with women in the most population. But this ratio is not constantly the best one to make, as women who have trouble getting pregnant, or those who have never been pregnant, are more likely to have ovarian cancer. So comparing women who have fertility problems but do not have IVF treatment with woman who have IVF treatment would tell us more about the risks involved with this kind of treatment.

And the new study said...

There were 77 ovarian cancers recorded on the whole. 61 in women who had IVF treatment and 16 in women who hadn't.

When only those women for whom the researchers had at least ten years of information were included in the analysis, women with fertility problems who had IVF treatment were more than twice as likely to have an ovarian tumour as women who hadn't. They were also twice as likely to have borderline ovarian tumours, which are not usually fatal, but which naturally need surgery. The risk of invasive tumours – those that spread to healthy parts of the ovary – was not higher than would be expected by chance.

There was no additional risk of ovarian cancer for women who had repeated courses of IVF treatment compared with women who had just one treatment. Women who had been cured with fertility drugs before going on to have IVF treatment did not have a higher risk of a tumour than those who had not.

The researchers counted that for women who have IVF treatment, the overall risk of a tumour in the ovaries is small. Less than one woman in one hundred – 0.45 percent of women – will gain ovarian cancer by the time they reach the age of 55. If the results of this study are correct, this risk increases to 0.71 percent for women who have IVF treatment.

Is this research reliable ?

This is a big study and one of the first to compare how habitual ovarian cancer is in women with fertility problems who had IVF treatment and those who hadn't. But the size of the group of women who did not have IVF was quite small by ratio with the number of women who had IVF, and this may mean the ratio were less accurate.

The researchers took into account some of the factors that could have influenced the results, such as age, the cause of their fertility problems and if and how many children women already had.

This type of study cannot tell if IVF treatment leads ovarian cancer, and still unknown whether it's IVF treatment, or ovarian stimulation, that increases the risk of ovarian cancer. For one quarter of the women in the study, the researchers did not know what fertility drugs, if any, they had taken, and this could have led to errors when counting these risks.

So, is it okay for you to grab IVF after ovarian cancer treatment ?

There's still needed further studies to prove that IVF can increase your chance for getting ovarian cancer. So, if you wanna grab IVF after you've ovarian cancer treatment, please, discuss it with your doctor for more informations and suggestions.


Source:
>>  besthealth.bmj.com


Image:
>> fwivf





All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

From Ultrasound Device, How Do You Think Ovarian Cancer Looks Like ?

In this post, i'm gonna talk about "From ultrasound device, how do you think ovarian cancer looks like ?"

There're various ovarian cancer in seriousness based from it's growth speed. They may be fluid-filled, solid or a combination of both. They may be especially solid, cystic or mixed

This type is hard to detect because it stills signless until moderately late in the disease process. Symptoms related with ovarian cancer are very non-certain and by the time a patient develops these symptoms, the ovarian cancer has often deploy to faraway sites. There are methods to test for the turn-out of ovarian cancer. This includes ultrasound and blood tests. So, from ultrasound device, how do you think ovarian cancer looks like ?.

The ultrasound inspection that you are suggested may be a transvaginal ultrasound or an abdominal ultrasound. Both of them may be applied to aid diagnose ovarian cancer. It can contribute to display whether the ovaries are ordinary in size. The ultrasound also informs us if the ovaries have a ordinary surface texture and whether there are cysts within the ovaries. The ultrasound can contribute to display whether a cyst has any solid areas as it is more likely to be cancer.

Actually, the image of ovarian cancer looks like on an ultrasound is different for everyone. Why ? Because, there are different ultrasound scoring methods which can foretell whether there is a malignancy or not. Some marks may point to increased chance of malignancy. These include cysts which have :

• A thick-walled cyst, a solid mass
• Abdomen and masses which are gradually enlarging.
• Large amount of free fluid in the pelvis
• Mixed cystic and solid masses OR
• Multiple septations within them,

Transvaginal ultrasound scanning has been taken, with some achievements, to recognize ovarian cancer. By the time the changes of ovarian cancer are detectable by ultrasound, general ovarian cancers are well beyond the early stage of the disease. In cases of ovarian cancer, ultrasound mostly shows complex cysts on

• One or both ovaries
• Abdominal fluid
• Multiple solid masses and/or
• Nodule on the bowel or excess pelvic

Ovarian cancer can't be diagnosed with assurance by ultrasound. The image of ovarian cancer looks like on an ultrasound can at best recognize marks that make it more likely to be vicious or docile. There are many docile pelvic conditions that can present on ultrasound and are mistaken for cancer. These include :

• Adhesions
• Dermoid cysts
• Docile ovarian cysts
• Endometriosis
• Fluid-filled faloppian tubes
• Hemorrhagic ovarian cysts
• Ovarian fibroids
• Pelvic abscesses
• Swollen AND
• Uterine fibroids

Source:
>> Artipot


Image:
>> sxc.hu





All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from some related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Beating Ovarian Cancer: How To Overcome The Odds And Reclaim Your Life [Paperback]

Here I come with a book that talks about ovarian cancer. This book is written by Chris Bledy. The title is Beating Ovarian Cancer: How To Overcome The Odds And Reclaim Your Life. The format of this book is paperback. Come with 224 pages, I hope you can learn more about ovarian cancer from this book.

A diagnosis of Ovarian Cancer does not have to be a death sentence. Recent improvement in medicine have made this once incurable disease treatable and manageable. You can beat advanced and even recurring, ovarian cancer. Simple but significant lifestyle changes can produce big results when it comes to healing.

Product Details

• Paperback: 224 pages
• List Price: $19.95 (Discount may awaiting for you)
• Author: Chris Bledy
• Publisher: Book Clearing House
• Publication Date: July 1, 2008
• Language: English
• ISBN-10: 1890427675
• ISBN-13: 978-1890427672
• Product Dimensions: 8.5 x 5.6 x 0.5 inches
• Shipping Weight: 12 ounces

All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 


The information and opinions expressed here are collected from many related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More

Did Your Families Have Ovarian Cancer Hereditary ? Be Aware !

In this post i'm gonna talk about "If your family have ovarian cancer history, is it can affect you ?"

It's a pain but it's a fact that if you have a family's member that have ovarian cancer history, then you MAY get that disease too. But not only that, if one of your family's member have breast cancer history, it can increase your percentage of getting ovarian cancer.

The fact is approximately 90% of ovarian cancers happen by chance, 10% of women with ovarian cancer have succeed genetic changes that tend them to ovarian cancer. There are three hereditary syndromes that affect to ovarian cancer:

1. Hereditary breast-ovarian cancer syndrome due to mutations in the tumor suppressor genes BRCA1 and BRCA2

Approximately 10% of women with ovarian cancer are bearers of a breast/ovarian cancer sensitivity gene. The proportion of cases of ovarian cancer appropriate to such a gene decreases with age and is estimated to be 14% for women diagnosed in the fourth decade, going down to 7% for women diagnosed in the sixth decade.

2. Hereditary Non-Polyposis Colorectal Cancer (Lynch syndrome II)

Hereditary Non-Polyposis Colorectal Cancer (HNPCC), also called Lynch syndrome II, is a hereditary syndrome most average marked by an increased risk for colorectal cancer. The lifetime risk of colorectal cancer is 80%, and is especially diagnosed in the individual's mid-40s. The risk of endometrial (uterine) cancer related with HNPCC is approximately 40%, while the risk of ovarian cancer is 10%. Other related cancers include biliary tract, urinary tract, small bowel and stomach.

3. Hereditary site-specific ovarian cancer.

Limited data are available on the site-specific ovarian cancer syndrome. This is the least average of the three hereditary cancer syndromes, and is marked by an increased risk of ovarian cancer. Findings from one group of investigators recommended that most families with this syndrome are associated to mutations in the BRCA1 gene.


Source:
>> Ovariancancer.jhmi.edu


Image:
>> sxc.hu





All materials on this website is provided for your general information ONLY and may not be construed as medical advice or instruction. No action or inaction should be taken based solely on the contents of this information; instead, readers should consult appropriate health professionals on any matter relating to their health and well-being. 

The information and opinions expressed here are collected from many related websites. But of course there're may some difference viewpoint, and i will try my best to offer you the good and relevant contents for you.

Read More